摘要
目的观察六君子汤预防晚期非小细胞肺癌患者化疗引起不良反应的作用。方法将60例ⅢB-Ⅳ期非小细胞肺癌患者随机分为治疗组(六君子汤加化疗)和对照组(单纯化疗),均治疗2个周期,比较两组不良反应。结果治疗组和对照组在Karnofsky评分、白细胞、中性粒细胞减少、血红蛋白减少、恶心呕吐方面程度低于对照组,两组比较差异均有统计学意义(P<0.05)。结论六君子汤能够减轻非小细胞肺癌患者化疗的不良反应,提高患者的生存质量。
Objective To observe the efficacy of Liujunzi decoction in preventing and treating adverse reaction of chemotherapy on advanced non-small cell lung cancer （NSCLC） . Methods Sixty patients with NSCLC in ⅢB-Ⅳ stage were randomly divided into two groups, the control group treated with chemotherapy alone and the treated group with chemothera- py and Liujunzi decoction. The therapeutic efficacy were evaluated after 2 treatment cycles. Results There were remarkable differences between the two groups in Kamofsky scoring （P 〈 0. 05）, leukopenia, neutropenia and hemoglobin level dessended, the treated group showed a better effect than the control group in reducing adverse reaction. Conclusion Liujunzi decoction could alleviate adverse reaction of chemotherapy and improve the quality of life.
出处
《广州医药》
2010年第2期68-70,共3页
Guangzhou Medical Journal
关键词
非小细胞肺癌
六君子汤
化疗
不良反应
Non-small cell lung cancer
Liujunzi decoction
Chemotherapy
Adverse reaction
